CPX-351 (Vyxeos)
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for CPX-351 (Vyxeos), covering 2017-08-22 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia [Phase 2]